Company / PP&E (Net)
Arcturus Therapeutics Holdings Inc. PP&E (Net) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$6.7M
FY2025
5-year range
$5.6M / $12.4M
FY2021-FY2025
Trend
-29.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $12M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +14.8%.
Declined from $12M to $7M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -18.4%
- 5-Year CAGR
- +14.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +14.8%, indicating consistent growth.
- In FY2025, pp&e (net) decreased 29.3% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.7M | -29.3% |
| FY2024 | $9.5M | -23.3% |
| FY2023 | $12.4M | +0.1% |
| FY2022 | $12.4M | +120.0% |
| FY2021 | $5.6M | +67.1% |
| FY2020 | $3.4M | +43.8% |
| FY2019 | $2.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026